Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 16:55:00 20/04/2026 BST			After hours 20:58:14
82.03 ^EUR	+0.01%		81.70	-0.40%

05:27pm	European Stocks Fall Sharply in Monday Trading as Hopes of Middle East Ceasefire Dim	MT
01:46pm	BNP Paribas Downgrades Sanofi to Neutral Rating, Cuts PT	MT

Sanofi Announces Resignation of Patrick Kron as Independent Director and Chairman of the Nomination, Governance and Csr Committee

Published on 03/05/2026 at 08:16 am GMT

S&P Capital IQ

SANOFI

+0.01%

Sanofi announced that Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29, 2026.

Latest news about Sanofi

05:27pm	European Stocks Fall Sharply in Monday Trading as Hopes of Middle East Ceasefire Dim	MT
01:46pm	BNP Paribas Downgrades Sanofi to Neutral Rating, Cuts PT	MT
12:50pm	BNP Paribas Downgrades Sanofi to Neutral From Outperform, Lowers Price Target to $50 From $59	MT
10:11am	Sanofi Says Its COVID-19 Vaccine Shows Better Tolerability Than Moderna Alternative in Phase 4 Trial	MT
09:34am	European markets plunge again
08:09am	Casino, Rubis, Sanofi... stocks to watch today in Paris
06:14am	Study shows Sanofi's Nuvaxovid better tolerated than Moderna's mNEXSPIKE
04-19	Sanofi Says COVID-19 Vaccine Shows Less Severe Side Effects in Study	MT
04-18	Sanofi's Nuvaxovid Covid-19 Vaccine Showed Better Tolerability Than Mnexspike in Head-To-Head Study	CI
04-18	Sanofi's Nuvaxovid Covid-19 vaccine showed better tolerability than Mnexspike in head-to-head study	RE
04-16	Vir Biotechnology, Inc. Receives $240 Million Upfront Payment and $75 Million Equity Investment from Astellas	CI
04-16	DKSH and Sanofi enter strategic partnership	RE
04-15	Evotec SE Appoints Ingrid Mller as Chief Operating Officer, Effective May 1, 2026	CI
04-15	Kazia Therapeutics Limited Appoints Dr. Sudha Rao as Chief Scientific Officer	CI
04-15	Sanofi and Regeneron?s Dupixent approval in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria	CI

Chart Sanofi

Duration

Period

SAN: Dynamic Chart

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).

Employees

74,846

Sector

Pharmaceuticals

Calendar

04-23 - Earnings release - Q1 2026

More about the company